Litcius/Paper detail

JAK inhibition for CD3− CD4+ lymphocytic-variant hypereosinophilic syndrome

Stanislas Faguer, Matthieu Groh, François Vergez, Mathilde Hunault, Nicolas Duployez, Yves Renaudineau, C. Paul, Guillaume Lefèvre, Jean‐Emmanuel Kahn

2023Clinical Immunology18 citationsDOIOpen Access PDF

Topics & Concepts

Hypereosinophilic syndromeImmunologyCD3MedicineEosinophiliaImmune systemCD8Eosinophilic Disorders and SyndromesEosinophilic EsophagitisImmune Cell Function and Interaction
JAK inhibition for CD3− CD4+ lymphocytic-variant hypereosinophilic syndrome | Litcius